Moderna’s stock gains as it announces authorization for its COVID-19 shot in India – MarketWatch

Shares of Moderna Inc. MRNA, +5.27% gained 6.3% in trading on Tuesday after the company said its COVID-19 vaccine has been authorized for adults in India. Moderna's shot has already been authorized in more than 50 countries, including the U.S. Moderna's stock is up 118.5% this year, while the broader S&P 500 SPX, +0.12% has gained 14.2%.

Originally posted here:

Moderna's stock gains as it announces authorization for its COVID-19 shot in India - MarketWatch

Related Posts
Tags: